<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04188782</url>
  </required_header>
  <id_info>
    <org_study_id>0362019</org_study_id>
    <nct_id>NCT04188782</nct_id>
  </id_info>
  <brief_title>Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure</brief_title>
  <official_title>Evaluation of the Development of Tolerance to Sevoflurane in Children Undergoing Repeated Anesthesia Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep sedation or general anesthesia is frequently required for infant that need radiotherapy
      to treat malignancies. As radiation therapy usually consist of several sessions, these
      patients are exposure to several consecutive anesthetic exposures (e.g. for some central
      nervous system tumors 30 sessions of radiotherapy are required). In our center, this 30-min
      anesthetic exposure are with sevoflurane. Considering that repeated daily exposure to such
      potent drugs, as general anesthetics, may induce tolerance, it is reasonable to explore
      whether this phenomenon is occurring in this population.

      The aim of this observational study was to determine if a repeated exposure to sevoflurane is
      associated with the development of clinical and electroencephalographic tolerance.

      We will enroll 16 pediatric patients, and we will measure the time needed to appropriately
      place the laryngeal mask (clinical effect) and we also will compare the
      electroencephalographic signal under anesthesia across the different sessions
      (electroencephalographic effect).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the development of tolerance to sevoflurane in
      children undergoing repeated drug exposure.

      We will evaluate the development of tolerance in two ways:

      Clinical: as the time needed to perform the inhalation induction, with a standardized
      protocol.

      Electroencephalographic: we will record every 3 sessions the electroencephalographic activity
      of the patients. We will perform classical spectral analysis, and coherence analysis as well.

      This observational study will be mainly exploratory since there are no other previous report
      in this topic
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Theta power in the EEG spectrum under anesthesia</measure>
    <time_frame>Last session of radiotherapy (compare to first session) - Up to 6 weeks</time_frame>
    <description>Theta power obtained from the EEG signal, with the patient under general anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Laryngeal Mask insertion</measure>
    <time_frame>Last session of radiotherapy (compare to first session) - Up to 6 weeks</time_frame>
    <description>The time in seconds between the induction beginning and the correct laryngeal mask placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha power in the EEG spectrum under anesthesia</measure>
    <time_frame>Last session of radiotherapy (compare to first session) - Up to 6 weeks</time_frame>
    <description>Alpha power obtained from the EEG signal, with the patient under general</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coherence</measure>
    <time_frame>Last session of radiotherapy (compare to first session) - Up to 6 weeks</time_frame>
    <description>Coherence between frontal electrodes in bands of the spectrum</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Anesthesia</condition>
  <condition>Tolerance</condition>
  <arm_group>
    <arm_group_label>Pediatric patients undergoing radiotherapy</arm_group_label>
    <description>Pediatric patients undergoing general anesthesia for radiotherapy treatment. General anesthesia will be accomplished exclusively by the administration of sevoflurane.
The inhalatory induction will be performed with sevofluorane at 8% with O2 4Lt/min. The maintenance will be with sevofluorane at an end tidal of 2.5% with 1Lt/min of O2.
The EEG will be obtain with SedLine monitor</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Describe how a reiterative anesthesia exposure could induce tolerance to the anesthetic.</description>
    <arm_group_label>Pediatric patients undergoing radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive pediatric patients schedule for radiotherapy treatment under general
        anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing radiotherapy

          -  Requiring general anesthesia

        Exclusion Criteria:

          -  Epilepsy

          -  Malignant Hyperthermia history
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Months</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonello Penna, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose I Egaña, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felipe Maldonado, Md MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rodrigo Gutierrez, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo G Gutierrez, MD PhD</last_name>
    <phone>56995993665</phone>
    <email>rggutierrez1@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto Nacional del Cancer</name>
      <address>
        <city>Santiago</city>
        <state>Metropolitana</state>
        <zip>7563215</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Gutierrez, MD</last_name>
      <phone>+56995993665</phone>
      <email>rggutierrez1@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Investigacion Clinica Avanzada</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <reference>
    <citation>Keidan I, Perel A, Shabtai EL, Pfeffer RM. Children undergoing repeated exposures for radiation therapy do not develop tolerance to propofol: clinical and bispectral index data. Anesthesiology. 2004 Feb;100(2):251-4.</citation>
    <PMID>14739796</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2019</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Rodrigo Gutiérrez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Electroencephalogram</keyword>
  <keyword>Spectral analysis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

